Non-squamous, metastatic non-small cell lung cancer: Retrospective c-met overexpression testing, patient characteristics, and treatment patterns

被引：0
|
作者：
Cai, Mona H. [1 ]
Choi, Yookyung Christy [1 ]
Vasilopoulos, Athan [1 ]
Liede, Alexander [1 ]
Lindsey, Sidney [2 ]
Raskin, Leon [1 ]
Truong, Ethan [2 ]
Fricke, Jeremy [2 ]
Gruber, Stephen [2 ]
Ansell, Peter [1 ]
机构：
[1] AbbVie, N Chicago, IL USA
[2] City Hope Natl Med Ctr, Duarte, CA USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
919
引用
收藏
页码：429 / 429
页数：1
相关论文
共 50 条
  • [41] Treatment patterns and cost-effectiveness of first line treatment of advanced non-squamous non-small cell lung cancer in Medicare patients
    Gilden, Daniel M.
    Kubisiak, Joanna M.
    Pohl, Gerhardt M.
    Ball, Daniel E.
    Gilden, David E.
    John, William J.
    Wetmore, Stewart
    Winfree, Katherine B.
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (02) : 151 - 161
  • [42] Discovery of LAH-1 as potent c-Met inhibitor for the treatment of non-small cell lung cancer
    Sima, Lijie
    Wang, Zhongyuan
    Yu, Ling
    Hou, Youli
    Zhao, Dongsheng
    Luo, Bilan
    Liao, Weike
    Liu, Xinfu
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2024, 39 (01) : 2286435
  • [43] Detecting C-MET Amplification in Blood and Tumor Tissue of Non-Small Cell Lung Cancer
    Fang, Meiyu
    Xu, Chunwei
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S356 - S356
  • [44] ADVERSE EFFECTS IN COMBINATION THERAPY WITH BEVACIZUMAB IN ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER - RETROSPECTIVE STUDY
    Cerna, Maria
    Berzinec, Peter
    Kasan, Peter
    Chowaniecova, Gabriela
    Martak, Marian
    Vesela, Milada
    Jancokova, Iveta
    Kuliskova, Iveta
    Mazal, Juraj
    Kavcova, Elena
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1199 - S1199
  • [45] EGFR/c-Met and mTOR signaling are predictors of survival in non-small cell lung cancer
    Crees, Zachary D.
    Shearrow, Caleb
    Lin, Leo
    Girard, Jennifer
    Arasi, Kavin
    Bhoraskar, Aayush
    Berei, Joseph
    Eckburg, Adam
    Anderson, Austin D.
    Garcia, Christian
    Munger, Ariana
    Palani, Sunil
    Smith, Thomas J.
    Sreenivassappa, Shylendra B.
    Vitali, Connie
    David, Odile
    Puri, Neelu
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [46] Clinical efficacy of bevacizumab combined with chemotherapy in the treatment of advanced non-squamous non-small cell lung cancer
    Liu, Yuhua
    Mao, Aihong
    Ma, Qin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (07): : 9049 - 9057
  • [47] Bevacizumab in the Treatment of Advanced, Non-Squamous Non-Small Cell Lung Cancer: An Evidence-Based Approach
    Tassinari, Davide
    Sartori, Sergio
    Papi, Maximilian
    Drudi, Fabrizio
    Castellani, Cinzia
    Carloni, Federica
    Tombesi, Paola
    Lazzari-Agli, Luigi
    ONCOLOGY, 2011, 80 (5-6) : 350 - 358
  • [48] Pemetrexed versus vinorelbine treatment of advanced non-squamous non-small cell lung cancer in elderly patients
    Chen, Yongshun
    Wen, Qinglian
    Liu, Hao
    Ao, Rui
    Wu, Xiaoyuan
    Guo, Leiming
    Wang, Wen
    He, Chunyu
    Wang, Jianhua
    MOLECULAR AND CLINICAL ONCOLOGY, 2013, 1 (03) : 553 - 557
  • [49] METRIX: International real-world study of c-Met protein overexpression in patients with non-small cell lung cancer
    Horinouchi, H.
    Xu, Z.
    Prince, S. Savic
    De la Iglesia, P.
    Enrico, D. H.
    Desmeules, P.
    Koslucher, A.
    Ansell, P. J.
    Thiebaut, R.
    Hader, C.
    ANNALS OF ONCOLOGY, 2024, 35 : S1643 - S1644
  • [50] Patient Characteristics and Treatment Patterns in Biomarker Selected Early Non-Small Cell Lung Cancer
    Abu Rous, Fawzi
    Sussell, Jesse
    Kochounian, Celina Ngiam
    Zhang, Qing
    Majda, Thomas
    Sheinson, Danny
    Ogale, Sarika
    Bara, Ilze
    Gadgeel, Shirish
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E47 - E47
12345